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were discussed, including day of the week and day between Monday and Friday. It 
was agreed that ‘weekdays’ could be translated as ‘working days’, and ‘weekends’ as 
‘Saturdays and Sundays’ while several languages preferred to use the English word. 
(3) 94% of languages struggled to find an equivalent for ‘skipping’. Many English back 
translations showed ‘hopping’ or ‘jumping’. The motion of skipping was discussed 
with translators as moving along lightly, stepping from one foot to the other with 
a hop or bounce. Many decided, on the absence of a similar word in their language, 
to replace this concept with ‘skipping with a rope’ which would work equally well 
as a ‘very active’ pastime. ConClusions: Similar issues often affect a number of 
languages. For such items, it may not be appropriate to produce literal translations 
and alternative solutions must be sought, taking into account linguistic features and 
cultural considerations, in order to achieve conceptual equivalence.
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objeCtives: The responsiveness of the EQ-5D to patient-level changes over time in 
respiratory diseases appears limited. This study aimed to explore the potential room 
for adding a respiratory dimension to the current EQ-5D descriptive system, i.e. a 
bolt-on dimension. Methods: First, the contents of the EQ-5D and six disease-spe-
cific health-related quality-of-life measures for asthma and COPD were reviewed. 
Second, a post-hoc analysis of data from three RCTs (N1= 5452, N2= 5992, N3= 1086) 
in which both EQ-5D and disease-specific quality-of-life were measured, was con-
ducted. Multivariate regression analyses were performed to investigate the change 
in the proportion of explained variance in EQ-5D VAS scores (R-square) when we 
added respiratory items of the disease-specific questionnaires to the EQ-5D dimen-
sion scores. Third, a principal component analysis (PCA) was performed to inves-
tigate the overlap between constructs of the disease-specific questionnaires and 
the EQ-5D. Results: The review showed that all disease-specific questionnaires 
include questions about the impact of asthma/breathlessness on physical activi-
ties, while the EQ-5D addresses physical activities in terms of impact on mobility, 
self-care and usual activity. Symptoms are addressed by five of the disease-specific 
questionnaires, while the EQ-5D covers them only broadly (pain/discomfort). Impact 
on functioning was included in four disease-specific questionnaires as well as the 
EQ-5D. Domains that were not included in the EQ-5D were impact on sleep and 
medication use. The regression analyses showed that the addition of questions 
about the impact of asthma/shortness of breath on physical activities led to the 
highest increase in R-square. In the PCA several disease-specific items were found 
that had no overlap with the EQ-5D. These constructs either related to symptoms or 
impact of breathlessness on activities. ConClusions: We conclude that symptoms 
and the impact of shortness of breath on physical activities are the most appropri-
ate respiratory bolt-on candidates. A valuation study including both candidates is 
currently ongoing.
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objeCtives: To study the effect of stress and coping resources on predicting gradu-
ate students’ quality of life measured by the WHOQOL-BREF. Methods: A battery 
of “Stress and Coping Resources” for graduate students was developed through a 
standard psychometric process. Four subscales are for Stress: relationship with 
advisor, future development, academic difficulty, and livelihood. Two scales are for 
Coping Resources: academic potential (knowledge, moral/ethic, resilience/endur-
ance, self-management, and teamwork) and interpersonal relationship (with family, 
friends, peer, and intimacy partner). In addition, the WHOQOL-BREF questionnaire 
was also used. A total of 1,760 participants including 920 males and 840 females MS 
students completed these scales. Regression analysis was conducted to study the 
effect of stress and coping resources on predicting each domain of the WHOQOL-
BREF. Results: The result showed that the stress of livelihood, academic difficulty 
and interpersonal relationship with family can jointly predict physical QOL. Most of 
the academic potential variables including knowledge, self-management, resilience/
endurance, and teamwork are good predictor variables to psychological QOL. Social 
QOL is predicted by the overall interpersonal relationship. Finally, Environmental 
QOL can be predicted by overall interpersonal relationship, and the stress from aca-
demic difficulty, future development, and relationship with advisor. ConClusions: 
The battery of “Stress and Coping Resources” was used to predict graduate students’ 
quality of life measured by the WHOQOL-BREF. The result showed that the subscales 
of stress and coping resources did predicted graduate students’ quality of life in 
various ways. Further study can be conducted to examine the mediate/moderate 
effect of coping resources on predicting QOL.
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objeCtives: Despite evidence of suboptimal adherence to Methotrexate (MTX), 
it remains the preferred initial antirheumatic drug. Several different tools assess 
overall medication adherence in rheumatoid arthritis (RA) but none is specific to 
MTX and adapted for routine clinical practice. The objective was to develop a tool to 
identify MTX-treated patients likely to be poor adherent to the medication, for use in 
routine clinical practice and in research studies. Methods: Exploratory interviews 
were conducted with 32 RA patients (US patients) currently or previously treated 
training was incorporated. In Round 2, participants reported improved usability 
as a result of the updates; three participants suggested increasing the font size 
on both devices, but only 1 participant reported difficulty selecting a response on 
the handheld. ConClusions: This study confirmed content equivalence between 
paper and electronic PSSD versions and demonstrated that both handheld and 
tablet are suitable for use in patients with plaque psoriasis with adequate front 
size on the devices.
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objeCtives: Endocrinologists and other clinicians who provide care to diabetic 
patients have ideal teaching opportunities to connect and deliver tobacco ces-
sation interventions in diabetes care. This study aimed to develop, validate and 
measure the reliability of a new tool that would be used to evaluate physicians’ 
attitudes and practices regarding tobacco cessation counselling in patients with 
diabetes, as well as barriers to deliver tobacco cessation counselling in their clin-
ics. Methods: This study was conducted from March till December 2012 in the 
endocrine clinic at Hospital Pulau Pinang, Malaysia. A standardised, 22-item, self-
administered questionnaire was developed to determine (i) physicians’ attitudes 
and practices regarding tobacco cessation counselling in patients with diabe-
tes, and (ii) barriers in delivering tobacco cessation counselling in their clinics. 
Face and content validity were assessed. Six pharmacists, whom were faculty 
members with experience and expertise in research and in the development of 
surveys, reviewed the questionnaire to assess its content validity.Reliability test 
was run along to check whether the new tool questions are correlated with one 
another adequatly or no. Results: Reliability test for the tool was pretested on 
a sample of 25 physicians physicians who ran the endocrine clinic at Hospital 
Pulau Pinang, Malaysia. Reliability analyses for the attitude domain and prac-
tice domain were 0.710 and 0.720, respectively. ConClusions: The question-
naire was valid and reliable to be use for the evaluation of physician’s barriers, 
attitude and practice regarding tobacco cessation counselling in the diabetics 
clinics.
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objeCtives: To elicit preferences for motor-symptoms, side-effects and process 
characteristics of competing treatments in Parkinson’s Disease and comparing 
within respondents a best-worst scaling profile (case 2) and multi-profile (case 
3) task. Methods: Seven attributes were derived from patients’ and neurolo-
gists’ interviews: treatment modality, tremors, slowness of movement, posture 
and balance problems, fatigue, dizziness, and dyskinesia. A profile (BWS2) and 
multi-profile (BWS3) best-worst scaling experiment were designed to observe if 
different types of BWS result in differences in valuation. In the BWS2, respondents 
were asked to select the aspects that they perceived as most and least preferable 
within one single treatment profile. For BWS3, respondents were asked to select 
the most and least desirable treatment from three profiles. Nine BWS2 and ten 
BWS3 tasks based on a D-efficient design were offered to 596 respondents from 
an internet panel. The data was analyzed with mixed conditional logit. For six 
predefined states, including best and worst, estimated utility values were cal-
culated. Results: The attributes’ rankings based on the relative importances 
differ slightly between tasks. Dizziness is most important attribute in BWS3 and 
tremors in BWS2. There was high agreement between estimated coefficients 
(r= 0.97). The slope between the coefficients is less than unity, suggesting that 
overall the BWS3 coefficients are scaled up to a larger extent than the BWS2 
coefficients. This implies smaller residual variance and lower decision uncer-
tainty with the BWS3 task. The estimated utilities’ rank order for the six states 
is the same for 64.4% of the respondents. One rank reversal occurs for 29% of the 
respondents. ConClusions: There is agreement on attribute importance and 
utility estimates both within and between respondents. There is yet no conclusive 
evidence for one of the two tasks, they both have their merits and depend on the 
context. The choice between them should be based on pretesting results, study 
goal and target population.
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tRanslation anD cultuRal aDaPtation Difficulties encounteReD 
DuRing linguistic valiDation of the haBitual activity estiMation 
scale (haes)
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objeCtives: - To investigate difficulties encountered during linguistic validation 
of the HAES into nineteen languages; - to discover whether certain source items 
consistently posed problems across multiple target languages; - to evaluate solu-
tions. Methods: - Collation of back translation reviews and developer reviews 
across nineteen languages; -identification of problematic words and phrases based 
on written discussion between lead translators, project managers and developer; - 
investigation of patterns across languages; - review of methods used to overcome 
difficulties. Results: Three principle issues were discovered and solutions found: 
(1) 52% of languages removed ‘A.M.’ and ‘P.M.’ due to use of the 24 hour clock. The 12 
hour clock markers were replaced with a word, like ‘Uhr’ in German; a letter, like ‘h’ 
in French; or simply numbers. (2) Ten languages had issues with the concepts ‘week-
day’ or ‘weekend’ as there is often no direct translation available. Various solutions 
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predominantly positive. However, experts refer to methodological deficits and only 
few would recommend the use of the instruments in practice. ConClusions: 
There are many questionnaires to assess workability and related concepts. 
However, only few seem to be scientifically sound and valid and at the same time 
applicable for a broad use in practice.
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objeCtives: Identify the principal challenges faced during migration from paper 
to electronic platform when placeholders are used within translated content, as 
eCOA questionnaires will often use placeholders which are replaced by other 
words/numbers when the software is running (string concatenation) Methods: 
110 reviews across 22 languages were collated; languages facing issues with place-
holders were identified; problems and resolutions were compared and results 
were reviewed in order to identify patterns. Results: Just over 40% of languages 
had issues with the population of software placeholders. Two main problems 
were found: (1) Issues involving articles and pronouns (including use of multiple 
articles/neutral pronouns/other gender agreements) – For example, Italian uses 
articles (al/alla) before a noun, so when a noun of either gender is electronically 
inserted into a sentence, the simplest resolution was to include all variations of 
the article before every placeholder. However in French where 3 kinds of article 
were required the result was too long, and a gender-neutral pronoun was used. 
(2) Some languages use two or more noun cases which raised issues. For example, 
Czech nouns change form depending on how they’re used in sentences but the 
running software inserted the same form of the noun everywhere. It was decided 
that the auto-populated text would be altered to fit the majority of cases, and 
instances which were an exception would be replaced with static text to ensure 
they appeared correctly. ConClusions: There are frequently issues with string 
concatenation that require in-depth discussion, as very few languages function 
in the same way as English. However, the issues that arose here could be resolved 
with careful consideration between the lead linguist and the project manager. 
All challenges were dealt with on an individual basis to attain a translation that 
reflects the source in the most natural way possible whilst still remaining true 
to the source.
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Reaney M1, Celeste Elash CA2
1ERT, Peterborough, UK, 2ERT, Pittsburgh, PA, USA
objeCtives: Patient-Reported Outcome (PRO) instruments are increasingly 
being utilized in drug development to provide a holistic understanding of the 
drugs impact. Such data can be beneficial in clinical decision making. This review 
sought to identify and discuss the PRO instruments used in Phase 3 trials of the 
newer classes of drugs for the treatment of Type 2 diabetes (T2DM). Methods: A 
search was conducted in medline, psychinfo, cinahl, and clinicaltrials.gov using 
17 drug names contained within the following classes: GLP-1 receptor agonists, 
novel insulins, SGLT-2 inhibitors, and DPP-4 inhibitors. This search was supple-
mented with EASD and ADA abstract database searches from 2012-2014. PRO 
instruments used in Phase 3 trials were identified and categorized by measure-
ment concept(s). The items and domains contained within the PRO instruments 
were further explored and summarized. Results: Twenty PRO instruments have 
been used, although none in DPP-4 inhibitor trials. PRO instruments were used 
to measure six separate concepts: treatment satisfaction (10/17 drugs), health-
related quality of life (HRQoL) (8/17), impact of weight/eating-related outcomes 
(6/17), symptoms of diabetes (3/17), psychological well-being (3/17), and cogni-
tive functioning (1/17). Although several PRO instruments were used to measure 
the same concept, the items and domains that comprised that concept differed 
across instruments. For example, only two of the seven treatment satisfaction 
questionnaires contain items pertaining to the injectable therapy device. In addi-
tion, some PRO instruments did not comprehensively evaluate the concept that 
they claimed. For example, an item-level analysis of the EQ-5D, identified as a 
measurement of HRQoL, suggests that it more accurately measures functional 
health status, thereby representing only one dimension of HRQoL. ConClusions: 
PRO data are available for many recently approved drugs in T2DM. More work 
is needed to highlight the relevance and importance of PRO data from pivotal 
trials as an important consideration for physicians when making treatment 
decisions.
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objeCtives: To develop a checklist of essential items, which authors should con-
sider when reporting studies of mapping to preference-based measures from other 
outcome measures. The aim of the checklist (the MApping onto Preference-based 
measures reporting Standards (MAPS) statement) is to promote complete and trans-
parent reporting by researchers. Methods: A working group of health economists 
and a Delphi methodologist was convened. Candidate items for the checklist were 
identified through a structured review of the literature and reviewed by the working 
group. A modified Delphi survey, with representatives from academia, consultancy, 
health technology assessment agencies and the biomedical journal editorial com-
munity, was used to identify a list of essential reporting items from the set of can-
with MTX alone or in combination, to explore their experience. Qualitative analysis 
was performed to develop a conceptual model of the factors influencing adher-
ence to MTX. Based on this model, items were generated using patients’ verbatim, 
and comprehension tested with 18 RA patients. Acceptability and applicability of 
the resulting pilot version were then assessed in clinical practice during consul-
tation, with 10 rheumatologists, using the PRAgmatic Content and face validity 
Test. Results: Several factors associated with poor adherence to MTX were elicited 
from the analysis of the exploratory interviews: barriers (practical, physical, emo-
tional, cognitive, financial), side effects, treatment perceived efficacy; doctor-related 
factors, patients’ beliefs, expectations and behaviors towards treatment, and exter-
nal sources. The resulting MTX Adherence Questionnaire included 29 questions, plus 
three about MTX administration mode and dose, divided into 5 sections: “Practical 
aspects of MTX”; “Me and MTX”; “Efficacy of MTX”; “My feelings about MTX”; “My 
opinion regarding my care”; “MTX treatment in general”. Rheumatologists accepted 
very well the questionnaire and found it useful to enhance communication with 
their patients (n= 8/10). ConClusions: The MTX Adherence Questionnaire is a 
patient self-administered tool that identifies patients facing adherence issues with 
MTX, and thereby helps clinicians make better-informed treatment decisions. It is 
suitable for use in clinical practice. A validation study to assess its robustness in 
research and clinical practice is being set up.
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objeCtives: Patients with chronic inflammatory disorders, such as rheumatoid 
arthritis (RA) or spondyloarthritis (SpA), have personal sets of fears and beliefs 
related to their disease that may influence the patient-physician relationship and 
treatment adherence. The objective was to describe the most frequent fears and 
beliefs in RA and SpA patients. Methods: Cross-sectional assessment of unse-
lected patients with a diagnosis of RA (ACR/EULAR criteria) or axial SpA (axSpA)
(ASAS criteria) in France in 2014. The study was proposed to all rheumatologists in 
France. A self-reported 44-item questionnaire (25 items on fears, 19 on beliefs) was 
built and preliminarily validated for this study. Each item was scored 0–10 (10 indi-
cating higher fears/stronger beliefs). The analysis was descriptive for the 5 fears and 
5 beliefs most frequently scored as ≥ 7/10, in both axSpA and RA patients. Results: 
Overall, 226 patients (161 RA, 65 axSpA; 64.4% female) were analyzed: mean dis-
ease duration 11.9 vs 13.8 years and mean patient’s global assessment 31/100 vs 
41/100 for RA vs axSpA patients, respectively. Of the 25 listed fears, the 6 most 
frequently reported were: “afraid of suffering again” (66.7% scored this as ≥ 7/10), 
“afraid of losing control and autonomy” (61.4%), “afraid of being a burden for rela-
tives” (59.6%), “afraid of losing all joint mobility” (58.9%), “afraid of the spread of 
the disease to other joints” (58.6%) and “afraid of the consequences of my disease 
on my professional activity” (58.6%). Of the 19 listed beliefs, the 5 most frequently 
reported were: “flares are triggered by fatigue” (41.7%), “physical activity reduces 
flares” (38.7%), “flares are triggered by changes in the weather” (37.3%), “flares are 
triggered by physical effort” (37.1%) and “the disease is linked to a genetic cause” 
(36.9%). ConClusions: This study highlights the main fears and beliefs from a 
patient perspective using a novel questionnaire specific to chronic inflammatory 
arthritis.
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objeCtives: Currently there is no standardized tool or questionnaire to measure 
workability and related concepts. Instead, there are various different instruments 
researchers and practitioners can choose between. However, a comprehensive 
review is still lacking and there is no evidence which instruments are used in prac-
tice. The objective of this paper is to identify, describe and evaluate the existing 
instruments for measuring workability, presenteeism, productivity and related 
concepts and to assess the status quo regarding the use and awareness of the 
instruments in Germany. Methods: We adopted a 2-step-approach: (1) PubMed, 
the Cochrane Library and ScienceDirect were searched for relevant articles pub-
lished before August 2014. Internet search and scanning reference lists comple-
mented our search. Two authors independently reviewed titles, assessed articles’ 
eligibility and extracted relevant data. Instruments identified in literature were 
briefly described and evaluated. (2) Experts from rehabilitation, health manage-
ment/economics and representatives of the medical profession were interviewed 
on their experiences with measuring workability. The survey was based on a 
semi-standardized, structured guideline and conducted by telephone. Results: 
(1) Systematic review revealed 4665 articles. Thereof 357 were included in further 
research. In total, we identified 57 instruments (including different versions of 
single instruments). Instruments vary significantly regarding content, response 
format, length, etc. Instruments most often used include WPAI, WLQ, SPS, HPQ, 
HLQ, WAI and MIDAS. (2) Results of the interviews indicate that the WAI and WPAI 
are the instruments most common and also most often used in Germany. Both 
tools are considered appropriate for measuring workability and experiences are 
